| Emily M Betz, OTR/L | |
|
10611 Baltimore St Ne Ste 200, Blaine, MN 55449-2846 | |
| (763) 755-4275 | |
| (763) 847-4814 |
| Full Name | Emily M Betz |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist - Pediatrics |
| Location | 10611 Baltimore St Ne Ste 200, Blaine, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184375453 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XP0200X | Occupational Therapist - Pediatrics | (* (Not Available)) | Primary |
| Provider Name | The Therapy Spot, Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1619446382 PECOS PAC ID: 3577894146 Enrollment ID: O20191011002244 |
News Archive
These have the potential to influence a young viewing audience* and their ideas about gender and violence. Her study is published in Springer's journal Sex Roles.
NexMed, Inc., a specialty CRO and a developer of products based on the NexACT® technology, today announced that pre-clinical results from its research and development group at Bio-Quant successfully demonstrated the ability of the NexACT technology to deliver an oral formulation of Taxol® (paclitaxel) and to enhance the drug's bioavailability by approximately ten-fold through this oral administration. Taxol, a first line chemotherapy drug used to treat breast, lung and ovarian cancers, is currently administered through an intravenous infusion that can take up to 24 hours to complete.
GE Capital, Healthcare Financial Services announced today that it was the sole lender on a $10 million senior secured multi-draw term loan to InfraReDx, Inc., a medical device company committed to advancing the diagnosis and management of coronary artery and other vascular diseases. The financing will be used to help support product commercialization efforts.
"A group of health organizations [on Wednesday] launched a new international consortium to better prepare the clinical research community to respond to the next pandemic or other emerging health threat," CIDRAP News reports (Schnirring, 12/7).
A key protein that causes the blood to clot is produced by blood vessels in the lungs and not just the liver, according to new research published today in the journal PLoS One, led by scientists at Imperial College London.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Emily M Betz, OTR/L 1891 Station Pkwy Nw, Andover, MN 55304-3341 Ph: (763) 755-4275 | Emily M Betz, OTR/L 10611 Baltimore St Ne Ste 200, Blaine, MN 55449-2846 Ph: (763) 755-4275 |
News Archive
These have the potential to influence a young viewing audience* and their ideas about gender and violence. Her study is published in Springer's journal Sex Roles.
NexMed, Inc., a specialty CRO and a developer of products based on the NexACT® technology, today announced that pre-clinical results from its research and development group at Bio-Quant successfully demonstrated the ability of the NexACT technology to deliver an oral formulation of Taxol® (paclitaxel) and to enhance the drug's bioavailability by approximately ten-fold through this oral administration. Taxol, a first line chemotherapy drug used to treat breast, lung and ovarian cancers, is currently administered through an intravenous infusion that can take up to 24 hours to complete.
GE Capital, Healthcare Financial Services announced today that it was the sole lender on a $10 million senior secured multi-draw term loan to InfraReDx, Inc., a medical device company committed to advancing the diagnosis and management of coronary artery and other vascular diseases. The financing will be used to help support product commercialization efforts.
"A group of health organizations [on Wednesday] launched a new international consortium to better prepare the clinical research community to respond to the next pandemic or other emerging health threat," CIDRAP News reports (Schnirring, 12/7).
A key protein that causes the blood to clot is produced by blood vessels in the lungs and not just the liver, according to new research published today in the journal PLoS One, led by scientists at Imperial College London.
› Verified 7 days ago
Jill Marie Akins, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 11855 Ulysses St Ne Ste 20, Blaine, MN 55434 Phone: 763-767-3140 | |
Chelsey Marie Joy Weintraub, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 12450 Cloud Dr Ne, Blaine, MN 55449 Phone: 763-777-7117 Fax: 651-401-0598 | |
Gregory Lee Rife, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 10230 Baltimore St Ne, Blaine, MN 55449 Phone: 651-968-5308 Fax: 651-730-3517 | |
Anna Caroline Morrison, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 11225 Ulysses St Ne, Blaine, MN 55434 Phone: 763-302-2600 Fax: 763-302-2601 | |
Marlee Olson, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 11517 Polk St Ne, Blaine, MN 55434 Phone: 218-838-7856 | |
Miss Amanda L Tschida-schirmers, OTR/L, CHT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 11225 Ulysses St Ne, Blaine, MN 55434 Phone: 763-302-2600 Fax: 763-302-2601 |